Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Reksa Dana Indeks Premier ETF IDX High Dividend 20 (XIHD)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan UBC Medical Indonesia Tbk. dan Reksa Dana Indeks Premier ETF IDX High Dividend 20: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Reksa Dana Indeks Premier ETF IDX High Dividend 20 diperdagangkan di Rp609 (kapitalisasi pasar 33,43 M, volume 24 jam 7,5 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 19× kapitalisasi pasar Reksa Dana Indeks Premier ETF IDX High Dividend 20, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 7,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | XIHD | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 33,43 M |
Volume | 843 rb | 7,5 rb |
Lot | 8,43 rb | 75 |
Perputaran | 137,6 jt | 4,51 jt |
Harga Rata-rata | 163,22 | 601 |
Nilai Transaksi | 137,6 jt | 4,51 jt |
Harga Ekuilibrium Indikatif | 165 | — |
Volume Ekuilibrium Indikatif | 246 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
